Notice of Proposed Sale · 144
Edgewise Therapeutics, Inc.
EWTXNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- EDGEWISE THERAPEUTICS INC
- Issuer CIK
- 0001710072
- SEC file number
- 001-40236
- Phone
- 7202627002
- Person for whose account securities are to be sold
- ALAN J RUSSELL
- Relationships to issuer
- Director · Officer
- Street
- 1715 38th Street
- City
- Boulder
- State / country code
- CO
- Postal code
- 80301
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 200,000 | 8,126,000.00 | 107,593,006 | 07/01/2026 | NASDAQ | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 07/01/2026 | Exercise of Stock Options | Issuer | 200,000 | N | 07/01/2026 | Cash |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 07/01/2026
- Signed
- /s/ Alan J Russell
- Plan adoption dates
- 03/13/2026
Company context
Edgewise Therapeutics is a leading biopharmaceutical company focused on novel, muscle-targeted therapeutics. Leveraging its expertise in muscle biology and small molecule drug development, Edgewise is advancing a cardiovascular pipeline targeting significant unmet needs, including hypertrophic cardiomyopathy, heart failure and other serious cardiovascular and cardiometabolic conditions. To learn more, go to edgewisetx.com or follow Edgewise on LinkedIn, X, Facebook and Instagram.